Sihuan Pharmaceutical Holdings Group Ltd
HKEX:460

Watchlist Manager
Sihuan Pharmaceutical Holdings Group Ltd Logo
Sihuan Pharmaceutical Holdings Group Ltd
HKEX:460
Watchlist
Price: 0.71 HKD
Market Cap: 6.6B HKD
Have any thoughts about
Sihuan Pharmaceutical Holdings Group Ltd?
Write Note

Relative Value

The Relative Value of one Sihuan Pharmaceutical Holdings Group Ltd stock under the Base Case scenario is 0.27 HKD. Compared to the current market price of 0.71 HKD, Sihuan Pharmaceutical Holdings Group Ltd is Overvalued by 62%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
0.27 HKD
Overvaluation 62%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
23
vs Industry
43
Median 3Y
3
Median 5Y
3
Industry
2.6
Forward
2.8
vs History
vs Industry
Median 3Y
-4.1
Median 5Y
-3.4
Industry
23
Forward
263.6
vs History
28
vs Industry
18
Median 3Y
20.8
Median 5Y
21.7
Industry
17.8
vs History
vs Industry
Median 3Y
-15.3
Median 5Y
4.8
Industry
25.4
vs History
22
vs Industry
58
Median 3Y
1.3
Median 5Y
1.2
Industry
2.2
vs History
31
vs Industry
78
Median 3Y
1.1
Median 5Y
1
Industry
2.8
Forward
1.2
vs History
28
vs Industry
81
Median 3Y
1.7
Median 5Y
1.4
Industry
5.4
vs History
0
vs Industry
20
Median 3Y
6
Median 5Y
5.1
Industry
13.7
Forward
-4.6
vs History
vs Industry
0
Median 3Y
-6.3
Median 5Y
0.3
Industry
17.2
Forward
-3.5
vs History
22
vs Industry
42
Median 3Y
8.4
Median 5Y
8.4
Industry
16.5
vs History
vs Industry
Median 3Y
-11.4
Median 5Y
-5.9
Industry
19.3
vs History
38
vs Industry
83
Median 3Y
0.4
Median 5Y
0.3
Industry
2

Multiples Across Competitors

Competitors Multiples
Sihuan Pharmaceutical Holdings Group Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Sihuan Pharmaceutical Holdings Group Ltd
HKEX:460
6.6B HKD 3.5 -163 95.7 -14.3
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
777.8B USD 19 92.9 49.9 55.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.2 34.9 24.3 27.7
US
Johnson & Johnson
NYSE:JNJ
367.4B USD 4.2 25 12.1 15.7
US
Merck & Co Inc
NYSE:MRK
249.6B USD 4 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
209.3B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
180.7B CHF 4.2 12.7 10 14.9
UK
AstraZeneca PLC
LSE:AZN
154.9B GBP 4 30.7 169 253.3
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
CN
Sihuan Pharmaceutical Holdings Group Ltd
HKEX:460
Average P/E: 33.6
Negative Multiple: -163
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
92.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
34.9
86%
US
Johnson & Johnson
NYSE:JNJ
25
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.7
21%
UK
AstraZeneca PLC
LSE:AZN
30.7
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A

See Also

Discover More
Back to Top